NYSE:USNA - New York Stock Exchange, Inc. - US90328M1071 - Common Stock - Currency: USD
31.78
-0.31 (-0.97%)
The current stock price of USNA is 31.78 USD. In the past month the price decreased by -7.7%. In the past year, price decreased by -34.84%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
UL | UNILEVER PLC-SPONSORED ADR | 23.29 | 138.82B | ||
HLN | HALEON PLC-ADR | 23.44 | 45.58B | ||
KVUE | KENVUE INC | 20.46 | 44.71B | ||
EL | ESTEE LAUDER COMPANIES-CL A | 30.3 | 25.83B | ||
BRBR | BELLRING BRANDS INC | 35.08 | 9.36B | ||
COTY | COTY INC-CL A | 20.39 | 4.98B | ||
IPAR | INTERPARFUMS INC | 28.81 | 4.30B | ||
ELF | ELF BEAUTY INC | 23.86 | 4.23B | ||
ODD | ODDITY TECH LTD-CL A | 22.92 | 2.51B | ||
EPC | EDGEWELL PERSONAL CARE CO | 10.64 | 1.50B | ||
OLPX | OLAPLEX HOLDINGS INC | 10.92 | 941.35M | ||
HLF | HERBALIFE LTD | 4.24 | 837.56M |
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,800 full-time employees. The firm operates through one segment: Direct-selling. Its two geographic regions include Asia Pacific, and Americas and Europe. The Company’s product lines include USANA Nutritionals Optimizers, Essentials/CellSentials, foods, personal care, skin care, and all others. The USANA Nutritionals Optimizers consist of supplements designed to meet individual health and nutritional needs. The Essentials/CellSentials product line includes vitamin and mineral supplements that provide total body nutrition. Its food product line includes meal replacement shakes, snack bars, and other related products. The company also offers products designed for prenatal, infant, and young-child age groups in China. The company distributes products internationally through direct selling, which entails person-to-person marketing and selling of products.
USANA HEALTH SCIENCES INC
3838 W Parkway Blvd
Salt Lake City UTAH 84120 US
CEO: Kevin G. Guest
Employees: 1800
Company Website: https://www.usana.com/
Investor Relations: https://ir.usana.com/
Phone: 18019547100
The current stock price of USNA is 31.78 USD. The price decreased by -0.97% in the last trading session.
The exchange symbol of USANA HEALTH SCIENCES INC is USNA and it is listed on the New York Stock Exchange, Inc. exchange.
USNA stock is listed on the New York Stock Exchange, Inc. exchange.
6 analysts have analysed USNA and the average price target is 52.53 USD. This implies a price increase of 65.29% is expected in the next year compared to the current price of 31.78. Check the USANA HEALTH SCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
USANA HEALTH SCIENCES INC (USNA) has a market capitalization of 605.73M USD. This makes USNA a Small Cap stock.
USANA HEALTH SCIENCES INC (USNA) currently has 1800 employees.
USANA HEALTH SCIENCES INC (USNA) has a resistance level at 32.88. Check the full technical report for a detailed analysis of USNA support and resistance levels.
The Revenue of USANA HEALTH SCIENCES INC (USNA) is expected to decline by -6.86% in the next year. Check the estimates tab for more information on the USNA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
USNA does not pay a dividend.
USANA HEALTH SCIENCES INC (USNA) will report earnings on 2025-02-25, after the market close.
The PE ratio for USANA HEALTH SCIENCES INC (USNA) is 11.23. This is based on the reported non-GAAP earnings per share of 2.83 and the current share price of 31.78 USD. Check the full fundamental report for a full analysis of the valuation metrics for USNA.
The outstanding short interest for USANA HEALTH SCIENCES INC (USNA) is 5.24% of its float. Check the ownership tab for more information on the USNA short interest.
ChartMill assigns a fundamental rating of 6 / 10 to USNA. USNA gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months USNA reported a non-GAAP Earnings per Share(EPS) of 2.83. The EPS decreased by -8.41% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 6.3% | ||
ROA | 8.09% | ||
ROE | 10.19% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 43% to USNA. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of -24.27% and a revenue growth -6.86% for USNA